Reprint
New Advances in Pharmacologic and Non-pharmacologic Therapy in Heart Failure and Heart Transplant
Edited by
May 2024
214 pages
- ISBN978-3-7258-1019-2 (Hardback)
- ISBN978-3-7258-1020-8 (PDF)
This book is a reprint of the Special Issue New Advances in Pharmacologic and Non-pharmacologic Therapy in Heart Failure and Heart Transplant that was published in
Medicine & Pharmacology
Public Health & Healthcare
Summary
In light of the continuous development of new pharmacological agents and device-based therapies, we made the decision to bring together the most innovative clinical studies and the most practical reviews as a part of this Special Issue to offer readers new evidence useful for the management of both patients with heart failure and heart transplant patients.
Format
- Hardback
License and Copyright
© 2024 by the authors; CC BY-NC-ND license
Keywords
heart failure; ejection fraction; network meta-analysis; SGLT2-inhibitors; vericiguat; omecamtiv mecarbil; heart failure; HFpEF; greater splanchnic nerve ablation; heart failure; chronic kidney disease; estimated glomerular filtration rate; sodium glucose linked transporters 2 inhibitors; treatment; angiotensin receptor blocker neprilysin inhibitors; heart failure with reduced ejection fraction; cardiorenal syndrome; angiotensin receptor–neprilysin inhibitors; reverse cardiac remodeling; renal resistance index; levosimendan; disease modifier drugs; advanced heart failure; heart failure reduced ejection fraction; heart failure; cardiorenal syndrome; autonomic dysregulation; respiratory disturbances; novel devices; cardiac contractility modulation; heart failure with reduced ejection fraction; global longitudinal strain; myocardial mechano-energetics efficiency; dapsone; transplant; G6PD; anemia; advanced heart failure; inodilators; levosimendan; pharmacologic therapy; cardiac contractility modulation; optimizer smart; heart failure reduced ejection fraction; tricuspid regurgitation; acute heart failure; calcium; inotropic agents; istaroxime; lusitropic agents; Na+/K+-ATPase; NKA; PST2744; SERCA2a; acute heart failure; biomarkers; cardiac ultrasound; computer tomography; therapeutic interventions; preventive strategies; cardiac contractility modulation; heart failure; amyloidosis; heart transplant; ABO subtype; rejection; heart failure; cardiogenic shock; cardiac transplantation; mechanical circulatory support; heart failure; mitral regurgitation; tricuspid regurgitation; atrial functional mitral regurgitation; atrial functional tricuspid regurgitation; transcatheter tricuspid valve intervention; atrial fibrillation; bleeding; direct oral anticoagulant; heart transplantation; oral anticoagulant; stroke; vitamin K antagonist; n/a